COPENHAGEN, Nov 6 (Reuters) – Danish drugmaker Leo Pharma is considering postponing its planned initial public offering until 2027 due to the ongoing turmoil in global financial markets, daily
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)